--- title: "Wolwo Pharma 2024 Q1-Q3 dividend distribution: 1 yuan for every 10 shares, with the record date on January 9" type: "News" locale: "en" url: "https://longbridge.com/en/news/223794546.md" description: "According to the announcement from WuXi AppTec, the company's equity distribution plan for the first three quarters of 2024 is: based on the current total share capital of the company, a cash dividend of RMB 1 (including tax) will be distributed for every 10 shares to all shareholders. The equity distribution record date is January 9, 2025, and the ex-dividend date is January 10, 2025" datetime: "2025-01-02T11:56:03.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/223794546.md) - [en](https://longbridge.com/en/news/223794546.md) - [zh-HK](https://longbridge.com/zh-HK/news/223794546.md) generator: "portal-rs" --- # Wolwo Pharma 2024 Q1-Q3 dividend distribution: 1 yuan for every 10 shares, with the record date on January 9 According to the announcement from WuXi AppTec (300357.SZ), the equity distribution plan for the first three quarters of 2024 is as follows: based on the company's existing total share capital, a cash dividend of RMB 1 per 10 shares (including tax) will be distributed to all shareholders. The equity distribution record date is January 9, 2025, and the ex-dividend date is January 10, 2025 ### Related Stocks - [300357.CN](https://longbridge.com/en/quote/300357.CN.md) ## Related News & Research - [The Outlook for a Smaller Ghana Cocoa Crop Supports Prices](https://longbridge.com/en/news/296516744.md) - [Copper Above $14,200 a Ton, With Global Inventory Shifts in Focus](https://longbridge.com/en/news/296771972.md) - [LibertyStream reports three months of battery-grade lithium carbonate output at 99.7%+ purity](https://longbridge.com/en/news/296788400.md) - [Cocoa Prices Fall on Rising Nigerian Cocoa Exports](https://longbridge.com/en/news/296637826.md) - [Weekly Recap: Two interim dividends paid and selective iron‑ore bidding](https://longbridge.com/en/news/296720277.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**